SCHEMBL30441973

SCHEMBL30441973

Fc1cc(F)c(CBr)cc1Br

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.33
KDM1A O60341 4/20 0.32
KCNH2 Q12809 2/20 0.32
KDM1B Q8NB78 2/20 0.32
IDO1 P14902 1/20 0.30
AGXT P21549 1/20 0.30
PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1262764 1.00 DPP4 (0.33) DPP4KDM1AKCNH2KDM1BIDO1
SCHEMBL377065 0.90 KDM1A (0.41) DPP4KDM1AKCNH2KDM1BIDO1
SCHEMBL29545980 0.90 KDM1A (0.41) DPP4KDM1AKCNH2KDM1BIDO1
SCHEMBL21521510 0.87 KDM1A (0.38) DPP4KDM1AKCNH2KDM1BPTPN1
SCHEMBL2528520 0.85 KDM1A (0.36) KDM1AKCNH2KDM1BPTPN1
SCHEMBL16860902 0.85 DPP4 (0.33) DPP4PTPN1
SCHEMBL344590 0.81 DPP4 (0.46) DPP4
SCHEMBL27893578 0.81 KDM1A (0.31) KDM1AKCNH2KDM1B
SCHEMBL18226969 0.81 DPP4 (0.39) DPP4IDO1AGXT
SCHEMBL28490129 0.79 KDM1A (0.38) KDM1AKDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118496142-A Aryl alkylamine compound and preparation method and application thereof 仁合益康集团有限公司 2024-08-16 CN disclosed
CN-110088089-B Benzyl amino pyridyl cyclopropane carboxylic acid, pharmaceutical composition and application thereof 勃林格殷格翰国际有限公司 2023-08-29 CN disclosed
CN-110177773-B Benzyl aminopyridine cyclopropanecarboxylic acid, pharmaceutical composition and application thereof 勃林格殷格翰国际有限公司 2023-08-25 CN disclosed
CN-110248929-B Benzyl amino pyrazinyl cyclopropanecarboxylic acid, pharmaceutical composition and use thereof 勃林格殷格翰国际有限公司 2023-05-12 CN disclosed